A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

ObjectiveThe purpose of this study is to establish an accurate prognostic model based on important clinical parameters to predict the overall survival (OS) of elderly patients with primary gastrointestinal diffuse large B-cell lymphoma (EGI DLBCL).MethodsThe Cox regression analysis is based on data...

Full description

Bibliographic Details
Main Authors: Junmin Wang, Weirui Ren, Chuang Zhang, Xiaoya Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.860993/full
_version_ 1818140827448246272
author Junmin Wang
Weirui Ren
Chuang Zhang
Xiaoya Wang
author_facet Junmin Wang
Weirui Ren
Chuang Zhang
Xiaoya Wang
author_sort Junmin Wang
collection DOAJ
description ObjectiveThe purpose of this study is to establish an accurate prognostic model based on important clinical parameters to predict the overall survival (OS) of elderly patients with primary gastrointestinal diffuse large B-cell lymphoma (EGI DLBCL).MethodsThe Cox regression analysis is based on data from the Surveillance, Epidemiology, and End Results (SEER) database.ResultsA total of 1,783 EGI DLBCL cases were eligible for the study [median (interquartile range, IQR) age, 75 (68–82) years; 974 (54.63%) males], of which 1,248 were randomly assigned to the development cohort, while 535 were into the validation cohort. A more accurate and convenient dynamic prognostic nomogram based on age, stage, radiation, and chemotherapy was developed and validated, of which the predictive performance was superior to that of the Ann Arbor staging system [C-index:0.69 (95% CI:0.67–0.71) vs. 56 (95%CI:0.54–0.58); P < 0.001]. The 3- and 5-year AUC values of ROC curves for 3-year OS and 5-year OS in the development cohort and the validation cohort were were alll above 0.7.ConclusionWe establish and validate a more accurate and convenient dynamic prognostic nomogram for patients with EGI DLBCL, which can provide evidence for individual treatment and follow-up.
first_indexed 2024-12-11T10:50:10Z
format Article
id doaj.art-abf6a4e7820a4033b5887e43ecc63ad7
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-11T10:50:10Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-abf6a4e7820a4033b5887e43ecc63ad72022-12-22T01:10:20ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-05-01910.3389/fmed.2022.860993860993A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell LymphomaJunmin Wang0Weirui Ren1Chuang Zhang2Xiaoya Wang3Department of Gastroenterology, The Third Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Gastroenterology, The Third Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Pediatric Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaJitang College of North China University of Science and Technology, Tangshan, ChinaObjectiveThe purpose of this study is to establish an accurate prognostic model based on important clinical parameters to predict the overall survival (OS) of elderly patients with primary gastrointestinal diffuse large B-cell lymphoma (EGI DLBCL).MethodsThe Cox regression analysis is based on data from the Surveillance, Epidemiology, and End Results (SEER) database.ResultsA total of 1,783 EGI DLBCL cases were eligible for the study [median (interquartile range, IQR) age, 75 (68–82) years; 974 (54.63%) males], of which 1,248 were randomly assigned to the development cohort, while 535 were into the validation cohort. A more accurate and convenient dynamic prognostic nomogram based on age, stage, radiation, and chemotherapy was developed and validated, of which the predictive performance was superior to that of the Ann Arbor staging system [C-index:0.69 (95% CI:0.67–0.71) vs. 56 (95%CI:0.54–0.58); P < 0.001]. The 3- and 5-year AUC values of ROC curves for 3-year OS and 5-year OS in the development cohort and the validation cohort were were alll above 0.7.ConclusionWe establish and validate a more accurate and convenient dynamic prognostic nomogram for patients with EGI DLBCL, which can provide evidence for individual treatment and follow-up.https://www.frontiersin.org/articles/10.3389/fmed.2022.860993/fullprimary gastric diffuse large B-cell lymphomaprognostic nomogramoverall survivaldynamically predictelderly patients
spellingShingle Junmin Wang
Weirui Ren
Chuang Zhang
Xiaoya Wang
A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
Frontiers in Medicine
primary gastric diffuse large B-cell lymphoma
prognostic nomogram
overall survival
dynamically predict
elderly patients
title A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
title_full A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
title_fullStr A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
title_full_unstemmed A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
title_short A New Staging System Based on the Dynamic Prognostic Nomogram for Elderly Patients With Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
title_sort new staging system based on the dynamic prognostic nomogram for elderly patients with primary gastrointestinal diffuse large b cell lymphoma
topic primary gastric diffuse large B-cell lymphoma
prognostic nomogram
overall survival
dynamically predict
elderly patients
url https://www.frontiersin.org/articles/10.3389/fmed.2022.860993/full
work_keys_str_mv AT junminwang anewstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT weiruiren anewstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT chuangzhang anewstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT xiaoyawang anewstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT junminwang newstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT weiruiren newstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT chuangzhang newstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma
AT xiaoyawang newstagingsystembasedonthedynamicprognosticnomogramforelderlypatientswithprimarygastrointestinaldiffuselargebcelllymphoma